Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Efficacy and safety of moxifloxacin in hospitalized patients with secondary peritonitis: pooled analysis of four randomized phase III trials.

De Waele JJ, Tellado JM, Weiss G, Alder J, Kruesmann F, Arvis P, Hussain T, Solomkin JS.

Surg Infect (Larchmt). 2014 Oct;15(5):567-75. doi: 10.1089/sur.2013.045. Epub 2014 May 15.

2.

Organ-focused mutual information for nonrigid multimodal registration of liver CT and Gd-EOB-DTPA-enhanced MRI.

Fernandez-de-Manuel L, Wollny G, Kybic J, Jimenez-Carretero D, Tellado JM, Ramon E, Desco M, Santos A, Pascau J, Ledesma-Carbayo MJ.

Med Image Anal. 2014 Jan;18(1):22-35. doi: 10.1016/j.media.2013.09.002. Epub 2013 Sep 13.

PMID:
24080528
3.

Randomised clinical trial of moxifloxacin versus ertapenem in complicated intra-abdominal infections: results of the PROMISE study.

De Waele JJ, Tellado JM, Alder J, Reimnitz P, Jensen M, Hampel B, Arvis P.

Int J Antimicrob Agents. 2013 Jan;41(1):57-64. doi: 10.1016/j.ijantimicag.2012.08.013. Epub 2012 Nov 13.

4.

Optimal multiresolution 3D level-set method for liver segmentation incorporating local curvature constraints.

Jimenez-Carretero D, Fernandez-de-Manuel L, Pascau J, Tellado JM, Ramon E, Desco M, Santos A, Ledesma-Carbayo MJ.

Conf Proc IEEE Eng Med Biol Soc. 2011;2011:3419-22. doi: 10.1109/IEMBS.2011.6090925.

PMID:
22255074
5.

3D liver segmentation in preoperative CT images using a level-sets active surface method.

Fernandez-de-Manuel L, Rubio JL, Ledesma-Carbayo MJ, Pascau J, Tellado JM, Ramon E, Desco M, Santos A.

Conf Proc IEEE Eng Med Biol Soc. 2009;2009:3625-8. doi: 10.1109/IEMBS.2009.5333760.

PMID:
19964309
6.

Consequences of inappropriate initial empiric parenteral antibiotic therapy among patients with community-acquired intra-abdominal infections in Spain.

Tellado JM, Sen SS, Caloto MT, Kumar RN, Nocea G.

Scand J Infect Dis. 2007;39(11-12):947-55. Epub 2007 Jun 5.

PMID:
17852889
7.

Prevention of infection following severe acute pancreatitis.

Tellado JM.

Curr Opin Crit Care. 2007 Aug;13(4):416-20. Review.

PMID:
17599012
8.

Early antibiotic treatment for severe acute necrotizing pancreatitis: a randomized, double-blind, placebo-controlled study.

Dellinger EP, Tellado JM, Soto NE, Ashley SW, Barie PS, Dugernier T, Imrie CW, Johnson CD, Knaebel HP, Laterre PF, Maravi-Poma E, Kissler JJ, Sanchez-Garcia M, Utzolino S.

Ann Surg. 2007 May;245(5):674-83.

9.

The need for new antimicrobials for intra-abdominal infections (IAI): defining the forthcoming scenario.

Tellado JM.

Surg Infect (Larchmt). 2006 Feb;7(1):1-4. No abstract available.

PMID:
16509779
10.

Empiric treatment of nosocomial intra-abdominal infections: a focus on the carbapenems.

Tellado JM, Wilson SE.

Surg Infect (Larchmt). 2005 Fall;6(3):329-43. Review.

PMID:
16201943
11.

[Guidelines for the empirical antibiotic treatment of intraabdominal infections].

Tellado JM, Sitges-Serra A, Barcenilla F, Palomar M, Serrano R, Barberán J, Moya M, Martínez M, García-Rodríguez JA, Mensa J, Prieto J.

Rev Esp Quimioter. 2005 Jun;18(2):179-86. Spanish. No abstract available.

12.

Ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections: results of a double-blind, randomized comparative phase III trial.

Solomkin JS, Yellin AE, Rotstein OD, Christou NV, Dellinger EP, Tellado JM, Malafaia O, Fernandez A, Choe KA, Carides A, Satishchandran V, Teppler H; Protocol 017 Study Group.

Ann Surg. 2003 Feb;237(2):235-45.

13.
14.

Defense mechanisms of the peritoneal cavity.

Broche F, Tellado JM.

Curr Opin Crit Care. 2001 Apr;7(2):105-16. Review.

PMID:
11373519
15.

Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES Study.

Reinhart K, Menges T, Gardlund B, Harm Zwaveling J, Smithes M, Vincent JL, Tellado JM, Salgado-Remigio A, Zimlichman R, Withington S, Tschaikowsky K, Brase R, Damas P, Kupper H, Kempeni J, Eiselstein J, Kaul M.

Crit Care Med. 2001 Apr;29(4):765-9.

PMID:
11373466
16.

In vivo neutrophil dysfunction in cirrhotic patients with advanced liver disease.

Fiuza C, Salcedo M, Clemente G, Tellado JM.

J Infect Dis. 2000 Aug;182(2):526-33. Epub 2000 Jul 24.

PMID:
10915084
17.

[Evidence-based medicine, health costs and treatment of intra-abdominal infection].

Badía X, Brosa M, Tellado JM.

Enferm Infecc Microbiol Clin. 1999;17 Suppl 2:86-94. Spanish.

PMID:
10605193
18.

[Evidence-based medicine in antimicrobial surgical prophylaxis].

Vega D, Tellado JM.

Enferm Infecc Microbiol Clin. 1999;17 Suppl 2:32-58. Review. Spanish.

PMID:
10605188
19.

A clinical trial on the prevention of catheter-related sepsis using a new hub model.

Segura M, Alvarez-Lerma F, Tellado JM, Jiménez-Ferreres J, Oms L, Rello J, Baró T, Sánchez R, Morera A, Mariscal D, Marrugat J, Sitges-Serra A.

Ann Surg. 1996 Apr;223(4):363-9.

20.

[Modulation of the inflammatory response in sepsis].

Tellado JM, Goyanes A, Jiménez Ferreres J.

Enferm Infecc Microbiol Clin. 1995 Jan;13(1):44-59. Review. Spanish. No abstract available.

PMID:
7893792
21.
22.
23.
24.

Altered neutrophil function following reperfusion of an ischemic myocutaneous flap.

Lee C, Kerrigan CL, Tellado JM.

Plast Reconstr Surg. 1992 May;89(5):916-23.

PMID:
1561262
26.

Anergic patients before elective surgery have enhanced nonspecific host-defense capacity.

Tellado JM, Giannias B, Kapadia B, Chartrand L, de Santis M, Christou NV.

Arch Surg. 1990 Jan;125(1):49-53.

PMID:
2153020
28.

The anergic state as a predictor of pancreatic sepsis.

García-Sabrido JL, Valdecantos E, Bastida E, Tellado JM.

Zentralbl Chir. 1989;114(2):114-20.

PMID:
2922967
29.

Predicting mortality based on body composition analysis.

Tellado JM, Garcia-Sabrido JL, Hanley JA, Shizgal HM, Christou NV.

Ann Surg. 1989 Jan;209(1):81-7.

Supplemental Content

Loading ...
Support Center